Comprehensive analysis of peripheral blood non-coding RNAs identifies a diagnostic panel for fungal infection after

Anli Yang1,2, Huadi Chen1,3,4, Jianwei Lin5

  • 1Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Bioengineered
|February 7, 2022
PubMed

Insights

Early diagnosis of fungal infections in transplant patients is crucial. Researchers developed a novel noncoding RNA panel for accurate detection, improving patient survival and quality of life.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Immunology

Background:

  • Fungal infections pose a significant threat to transplant recipients' survival and quality of life.
  • Early and accurate diagnosis is critical for effective management of post-transplant fungal infections.

Purpose of the Study:

  • To develop a novel diagnostic method for early detection of fungal infections in transplant patients.
  • To identify specific noncoding RNAs (miRNAs and lncRNAs) as potential biomarkers for fungal infection.

Main Methods:

  • Established a post-transplant immunosuppressed mice model with fungal inoculation.
  • Screened differentially expressed miRNAs and lncRNAs using microarray analysis.
  • Validated candidate RNAs in peripheral blood samples from transplant patients using qRT-PCR.
  • Developed a diagnostic panel using support vector machine analysis.

Main Results:

  • Identified specific up-regulated (miR-215, miR-let-7c) and down-regulated (miR-154, miR-193a, NR_027669.1, NR_036506.1) noncoding RNAs in patients with fungal infection.
  • Established a 6-noncoding-RNA detection panel with high diagnostic efficacy (AUC=0.927, accuracy=0.928).
  • The panel demonstrated excellent sensitivity (0.944) and specificity (0.910) in distinguishing infected patients.

Conclusions:

  • A novel 6-noncoding RNA panel shows high potential for accurate and early diagnosis of fungal infections in transplant patients.
  • The identified noncoding RNAs serve as promising biomarkers for fungal infection detection.
  • Further multi-center prospective clinical trials are needed to confirm the clinical application value of this diagnostic panel.

Related Concept Videos